Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumab

American Journal of Ophthalmology

Volumn 156, Issue 1, 2013, Pages

  Bloch, Sara Brandi ^a,b   Lund Andersen, Henrik ^a,b   Sander, Birgit ^a   Larsen, Michael ^a,b,c  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OCULAR FIBROSIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SUBFOVEAL FIBROSIS; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 84879223893     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2013.02.012     Document Type: Article

References (34)

1. P.J. Rosenfeld, D.M. Brown, and J.S. Heier MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
2. D.M. Brown, P.K. Kaiser, and M. Michels ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1432 1444
3. N.M. Bressler Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2 Arch Ophthalmol 119 2 2001 198 207
4. Macular Photocoagulation Study Group Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group Arch Ophthalmol 109 8 1991 1109 1114
5. T.Y. Wong, U. Chakravarthy, and R. Klein The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis Ophthalmology 115 1 2008 116 126
6. S.R. Chandra, E.S. Gragoudas, E. Friedman, E.M. Van Buskirk, and M.L. Klein Natural history of disciform degeneration of the macula Am J Ophthalmol 78 4 1974 579 582
7. W.R. Green, and C. Enger Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture Ophthalmology 100 10 1993 1519 1535
8. A. Skaat, A. Chetrit, M. Belkin, M. Kinori, and O. Kalter-Leibovici Time trends in the incidence and causes of blindness in Israel Am J Ophthalmol 153 2 2012 214 221
9. N.M. Bressler Age-related macular degeneration is the leading cause of blindness JAMA 291 15 2004 1900 1901
10. P.K. Kaiser, B.A. Blodi, H. Shapiro, and N.R. Acharya Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 10 2007 1868 1875
11. S.B. Bloch, M. Larsen, and I.C. Munch Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010 Am J Ophthalmol 153 2 2012 209 213
12. P.J. Rosenfeld, H. Shapiro, L. Tuomi, M. Webster, J. Elledge, and B. Blodi Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials Ophthalmology 118 3 2011 523 530
13. R. Klein, M.D. Davis, Y.L. Magli, P. Segal, B.E. Klein, and L. Hubbard The Wisconsin age-related maculopathy grading system Ophthalmology 98 7 1991 1128 1134
14. Age-Related Eye Disease Study Research Group The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study report number 6 Am J Ophthalmol 132 5 2001 668 681
15. J.A. Chamberlin, N.M. Bressler, and S.B. Bressler The use of fundus photographs and fluorescein angiograms in the identification and treatment of choroidal neovascularization in the Macular Photocoagulation Study. The Macular Photocoagulation Study Group Ophthalmology 96 10 1989 1526 1534
16. Macular Photocoagulation Study Group Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group Arch Ophthalmol 109 9 1991 1242 1257
17. J.D. Gass Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes Am J Ophthalmol 118 3 1994 285 298
18. H.E. Grossniklaus, and J.D. Gass Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes Am J Ophthalmol 126 1 1998 59 69
19. H.E. Grossniklaus, and W.R. Green Choroidal neovascularization Am J Ophthalmol 137 3 2004 496 503
20. B.A. Lafaut, K.U. Bartz-Schmidt, C. Vanden Broecke, S. Aisenbrey, J.J. De Laey, and K. Heimann Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation Br J Ophthalmol 84 3 2000 239 243
21. Submacular Surgery Trials Research Group Comparison of two-dimensional reconstructions of surgically excised subfoveal choroidal neovascularization with fluorescein angiographic features: SST report no. 15 Ophthalmology 113 2 2006 267 279
22. A.H. Rogers, A. Martidis, P.B. Greenberg, and C.A. Puliafito Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization Am J Ophthalmol 134 4 2002 566 576
23. A.E. Fung, G.A. Lalwani, and P.J. Rosenfeld An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 4 2007 566 583
24. S. Liakopoulos, S. Ongchin, and A. Bansal Quantitative optical coherence tomography findings in various subtypes of neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 49 11 2008 5048 5054
25. S. Joeres, J.W. Tsong, and P.G. Updike Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 48 9 2007 4300 4307
26. P.A. Keane, S. Liakopoulos, and S.C. Ongchin Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration Invest Ophthalmol Vis Sci 49 7 2008 3115 3120
27. P.A. Keane, K.T. Chang, S. Liakopoulos, R.V. Jivrajka, A.C. Walsh, and S.R. Sadda Effect of ranibizumab retreatment frequency on neurosensory retinal volume in neovascular amd Retina 29 5 2009 592 600
28. S.A. Zweifel, N. Saroj, H. Shapiro, and K.B. Freund The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration Retina 32 7 2012 1243 1249
29. M.L. Klein, P.A. Jorizzo, and R.C. Watzke Growth features of choroidal neovascular membranes in age-related macular degeneration Ophthalmology 96 9 1989 1416 1419
30. S.L. Friedman, D. Sheppard, J.S. Duffield, and S. Violette Therapy for fibrotic diseases: nearing the starting line Sci Transl Med 5 167 2013 1 17
31. SK Mukkamala, RA Costa, A Fung, D Sarraf, R Gallego-Pinazo, and KB Freund Optical coherence tomographic imaging of sub-retinal pigment epithelium lipid Arch Ophthalmol 130 12 2012 1547 1553
32. N. Jo, C. Mailhos, and M. Ju Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization Am J Pathol 168 6 2006 2036 2053
33. Ophthotech Corp. Ophthotech's novel anti-PDGF combination agent Fovista demonstrated superior efficacy over Lucentis monotherapy in large controlled wet AMD trial. Available at: http://www.ophthotech.com/ophthotechs-anti-pdgf- fovista-superior-efficacy-phase2b/. Accessed January 28, 2013.
34. H. Zhang, and Z.L. Liu Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model Int J Ophthalmol 5 3 2012 307 311